Purpose: To evaluate the efficacy and safety of 3D-printed tissue compensations in breast cancer patients receiving breast reconstruction and postmastectomy radiotherapy (PMRT).
Methods And Materials: We enrolled patients with breast cancer receiving breast reconstruction and PMRT. The dose distribution of target and skin, conformability, and dose limit of organs at risk (OARs) were collected to evaluate the efficacy of the 3D-printed bolus. Radiation Therapy Oncology Group (RTOG) radiation injury classification was used to evaluated the skin toxicities.
Results: A total of 30 patients diagnosed between October 2019 to July 2021 were included for analysis. Among all the patients, the 3D-printed bolus could ensure the dose coverage of planning target volume (PTV) [homogeneity index (HI) 0.12 (range: 0.08-0.18)], and the mean doses of D99%, D98%, D95%, D50%, D2% and Dmean were 4606.29cGy, 4797.04cGy, 4943.32cGy, 5216.07cGy, 5236.10cGy, 5440.28cGy and 5462.10cGy, respectively. The bolus demonstrated an excellent conformability, and the mean air gaps between the bolus and the chest wall in five quadrants were 0.04cm, 0.18cm, 0.04cm, 0.04cm and 0.07cm, respectively. In addition, the bolus had acceptable dosage limit of OARs [ipsilateral lung: Dmean 1198.68 cGy, V5 46.10%, V20 21.66%, V30 16.31%); heart: Dmean 395.40 cGy, V30 1.02%, V40 0.22%; spinal cord planning risk volume (PRV): Dmax 1634 cGy] and skin toxicity (grade 1, 76.0%; grade 2, 21.0%; grade 3, 3.3%).
Conclusion: The 3D-printed bolus offers advantages in terms of dose uniformity and controllable skin toxicities in patients receiving breast reconstruction and PMRT. Further research is needed to comprehensively evaluate the effectiveness of the 3Dprinted bolus in this patient subset.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10751906 | PMC |
| http://dx.doi.org/10.3389/fonc.2023.1239636 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A case study on postoperative radiation therapy of the big toe.
Med Dosim
January 2025
Medical Dosimetry Program at the University of Wisconsin - La Crosse, La Crosse, WI, 54601, USA.
Sweat gland cancers, particularly eccrine sweat gland carcinomas, are rare and challenging to treat due to their aggressive nature and inconspicuous clinical presentation. Aggressive digital papillary adenocarcinoma, a rare subtype, frequently presents with delays in diagnosis, increasing the risk of metastasis and recurrence. Surgical excision remains the standard treatment, but the role of postoperative radiation therapy is not well-established due to the paucity of data.
View Article and Find Full Text PDFBody contour adaptation for weight-loss and bolus for head and neck radiotherapy on Ethos version 2.0 and HyperSight: Synthetic CT versus direct calculation.
J Appl Clin Med Phys
December 2024
Department of Physics and Atmospheric Sciences, Dalhousie University, Halifax, Canada.
Purpose: In radiotherapy, body contour inaccuracies may compromise the delineation of adjacent structures and affect calculated dose. Here, we evaluate the un-editable body contours auto-generated by Ethos versions 1.0 (v1) and 2.
View Article and Find Full Text PDFExploring the impact of filament density on the responsiveness of 3D-Printed bolus materials for high-energy photon radiotherapy.
Phys Med
November 2024
Faculty of Physics, Babeș-Bolyai University, Cluj-Napoca, Romania. Electronic address:
Background: 3D-printed boluses in radiation therapy receive consideration for their ability to enhance treatment precision and patient comfort. Yet, thorough validation of 3D-printed boluses using various validation procedures and statistical analysis is missing. This study aims to determine the effectiveness of using 3D-printed boluses in radiation therapy.
View Article and Find Full Text PDFCharacterization of brass mesh bolus for electron beam therapy.
Biomed Phys Eng Express
October 2024
Department of Radiation Oncology, Northwestern University, Chicago, IL, 60611, United States of America.
Article Synopsis
- - Brass mesh boluses are used to minimize air gaps on complex body surfaces during radiation therapy, improving dosimetry for targeting tumors near the skin, especially in patients requiring electron radiation.
- - A study investigated the dosimetric properties of brass mesh boluses for 6, 9, and 12 MeV electrons, revealing that these boluses can significantly increase the surface dose, ranging from 94% of the dose at a defined depth based on the electron energy used.
- - Results showed that the brass mesh bolus is comparably effective to traditional water-equivalent boluses, and modeling in treatment planning systems (TPS) aligns closely with the measured data, suggesting they can enhance treatment efficiency for electron therapy protocols.
A Customized 3D-Printed Bolus for High-Risk Breast Cancer with Skin Infiltration: A Pilot Study.
Curr Oncol
September 2024
Medical Physics Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Background: In high-risk breast cancer patients with skin infiltration, the administration of a uniform dose to superficial tissues is fundamental in order to reduce local skin relapse. A personalized bolus may prevent the potential inadequate dose distribution of a standard bolus due to air gaps between the bolus and the skin. In this pilot study, we introduced into clinical practice the use of a personalized 3D-printed bolus filled with ultrasound transmission gel.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!